Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07220356Phase 4Active, not recruiting
Phase 4, randomised, open-label trial (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Acceptability and Feasibility as assessed by number of participants who complete modules at 1 month, Acceptability and Feasibility as assessed by number of sessions with CHW at 6 months and 1 more. Started Dec 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07220356.